Kamilah Alexander

Kamilah Alexander joined our New Lawyers Group (NLG) in 2015. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day. Kamilah will be focusing on intellectual property matters, including transactions, litigation, diligence, and prosecution.

Prior to attending law school, Kamilah worked at Pulmatrix, an early-stage clinical biotechnology company, and at an IP boutique law firm in Boston, Massachusetts. She has a technology background in cell signaling, molecular biology, cell biology, genetics, and cancer biology. Her experience includes tissue culture, immunofluorescence, flow cytometry, microscopy, and protein biochemistry. While earning her doctorate degree, Kamilah conducted research on the cell signaling pathways involved in cellular senescence, focusing on how mutations in cell cycle tumor suppressor proteins allowed cells to escape senescence and become cancerous. [1]